These together with our always on campaigns, delivered growth in our new patient registrations of 6.1% and resulted in increases in our market share across Australia of 1.5% vs prior year.

Marketing Drivers of Growth

  • Brand Differentiation
  • Patient Acquisition
  • Lifecycle Engagement
  • Marketing Effectiveness

Outcomes vs FY23

  • 6.1% increase in New patient registrations
  • 1.5% increase in market share across key markets


Endometriosis Campaign
Monash IVF Group launched an endometriosis campaign targeting the 11% of Australians who are affected by endometriosis and require fertility treatment. This campaign aimed to raise awareness and educate the public on the link between endometriosis and fertility challenges.

Fertility Health Assessments
Our fertility health assessment is designed to support people who have been unable to resolve their concerns about their reproductive health. The service allows them to readily access medical professionals with deep expertise in women’s health and provides a comprehensive fertility assessment that identifies underlying issues and triages patients for treatment, if required.

Community Support and Partnerships
Our partnership with the Australian Athletes Alliance has continued to deepen, with increasing community support being extended each year. We have now partnered with two athletes – Chloe Dalton, former Rugby 7s Olympic Gold medallist and current GWS Giants AFLW player and Emily Gielnik, Melbourne Victory and Matildas player.

Our ambassadors are helping to break down stigmas and enhancing our brand visibility and resonance, particularly among sports enthusiasts and athletes.

Public Relations and Share of Voice
Public relations has been a cornerstone of our brand strategy, resulting in a remarkable increase in our PR share of voice of 60%, outpacing our competitors. Through strategic PR campaigns we have strengthened our brand’s presence and credibility in the fertility sector.

These efforts have positioned Monash IVF Group as a trusted and authoritative voice in fertility treatment.